Clinical Trials Browser

Has results × Lymphoma × HhAntag691 × Clear all

NCT06357988 2026-05-28

Testing GDC-0449 (Vismodegib) as Potentially Targeted Treatment in Cancers With Smoothened or Patched 1 Mutant Tumors (MATCH - Subprotocol T)

Phase 2 Active not recruiting

34 enrolled 10 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma